Selection of aptamers against triple negative breast cancer cells using high throughput sequencing

Selection of aptamers against triple negative breast cancer cells using high throughput sequencing

Abstract Triple-negative breast cancer is the most aggressive subtype of invasive breast cancer with a poor prognosis and no approved targeted therapy. Hence, the identification of new and specific ligands is essential to develop novel targeted therapies. In this study, we aimed to identify new apta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Débora Ferreira, Joaquim Barbosa, Diana A. Sousa, Cátia Silva, Luís D. R. Melo, Meltem Avci-Adali, Hans P. Wendel, Ligia R. Rodrigues
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/6c99aaffdcdf46e9a9583ba91d206a71
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares